Lupin intros Tydemi, its Safyral generic

Press enter to search
Close search
Open Menu

Lupin intros Tydemi, its Safyral generic

By David Salazar - 03/14/2018
Lupin has launched its contraceptive Tydemy, which was approved by the Food and Drug Administration in December as a generic of Bayer’s Safyral. Tydemy, (drospirenone, ethinyl estradiol, and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg) are indicated to preven pregnancy and raise folate levels in women who prefer an oral contraceptive.

The drug had U.S. sales of roughly $22 million for the 12 months ended January 2018.

Related Topics